The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
The new study, published in @geroscience by Max Shokhirev and Adiv Johnson, compared all the major DNA methylation clocks (most of them commercially available) and found CheekAge had the best association with diseases & medical conditions...
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
This is how various clocks stack up associating with cancers: CheekAge (cheek sample), DNAm PhenoAge, Zhang 2019, Horvath 2018, Horvath 2013, and Hannum 2013 (blood samples)